We also looked for alpha-thalassemia/mental retardation (ATRX) gene mutation status, since ATRX loss by immunohistochemistry is characteristic, but not required for diagnosis of diffuse astrocytoma, IDH-mutant by the WHO. The gene discussed is IDH1; the disease is diffuse astrocytoma.